<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>AXIM BIOTECHNOLOGIES RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Thu, 19 Nov 2026 11:30:12 +0100</lastBuildDate><atom:link href="https://www.finanzen.net/rss/axim%5Fbiotechnologies%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>AXIM BIOTECHNOLOGIES RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>EQS-News: AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease</title><pubDate>Tue, 06 Oct 2026 15:00:21 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-axim-biotechnologies-submits-510-k-to-fda-for-next-generation-rapid-point-of-care-tear-lactoferrin-test-for-dry-eye-disease-15969507</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: AXIM Biotech


 / Key word(s): Financial


<br/>


AXIM Biotechnologies Submits 510(k) to FDA for Next-Generation, Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-axim-biotechnologies-submits-510-k-to-fda-for-next-generation-rapid-point-of-care-tear-lactoferrin-test-for-dry-eye-disease-15969507</guid></item></channel></rss>
